US Markets for Peripheral Vascular Devices 2007

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US PERIPHERAL VASCULAR DEVICE OVERVIEW

• 1.1 Market Overview
  • 1.1.1 Procedures, by Type
    • 1.1.1.1 Endovascular Procedures
    • 1.1.1.2 Surgical Procedures
  • 1.1.2 Procedures, by Indication
    • 1.1.2.1 Carotid
    • 1.1.2.2 Renal
    • 1.1.2.3 Iliac
    • 1.1.2.4 Lower Extremity
    • 1.1.2.5 Aorta
    • 1.1.2.6 Arteriovenous Access
    • 1.1.2.7 Inferior Vena Cava Filters
    • 1.1.2.8 Emerging PVD Device Technology

2.0 US PERIPHERAL VASCULAR DEVICE MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Procedures
  • 2.2.2 Market Forecast
  • 2.2.3 Market Drivers and Limiters
• 2.3 Competitive Analysis

3.0 PERIPHERAL VASCULAR STENT MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Procedures
  • 3.2.2 Procedures, by Stent Type
    • 3.2.2.1 Bare-Metal Stent Procedures
    • 3.2.2.2 Covered Stent Procedures
  • 3.2.3 Procedures, by Indication
    • 3.2.3.1 Carotid Artery Stenting
    • 3.2.3.2 Renal Artery Stenting
    • 3.2.3.3 Iliac Artery Stenting
    • 3.2.3.4 Femoral Popliteal Artery Stenting
    • 3.2.3.5 Infrapopliteal Artery Stenting
    • 3.2.3.6 Other Stenting
  • 3.2.4 Market Forecast
  • 3.2.5 Market Forecast, by Stent Type
    • 3.2.5.1 Bare-Metal Stent Market
    • 3.2.5.2 Covered Stent Market
  • 3.2.6 Market Forecast, by Indication
    • 3.2.6.1 Carotid Stent Market
    • 3.2.6.2 Renal Stent Market
    • 3.2.6.3 Iliac Stent Market
    • 3.2.6.4 Femoral-Popliteal Stent Market
    • 3.2.6.5 Infrapopliteal Stent Market
    • 3.2.6.6 Other Stent Market
  • 3.2.7 Market Drivers and Limiters
• 3.3 Competitive Analysis

4.0 PTA BALLOON CATHETER MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedures
    • 4.2.1.1 Carotid Artery PTA Procedures
    • 4.2.1.2 Renal Artery PTA Procedures
    • 4.2.1.3 Iliac Artery PTA Procedures
    • 4.2.1.4 Femoral-Popliteal PTA Procedures
    • 4.2.1.5 Infrapopliteal PTA Procedures
    • 4.2.1.6 Arteriovenous PTA Procedures
    • 4.2.1.7 Other PTA Procedures
  • 4.2.2 Market Forecast
    • 4.2.2.1 Standard PTA Market
    • 4.2.2.2 Small PTA Market
    • 4.2.2.3 High-Pressure PTA Market
    • 4.2.2.4 Specialty PTA Market
    • 4.2.2.5 Large PTA Market
  • 4.2.3 Market Drivers and Limiters
• 4.3 Competitive Analysis

5.0 EMBOLIC PROTECTION DEVICE MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Procedures
    • 5.2.1.1 Carotid EPD Procedures
    • 5.2.1.2 Renal EPD Procedures
    • 5.2.1.3 Other EPD Procedures
  • 5.2.2 Market Forecast
    • 5.2.2.1 Carotid EPD Market
    • 5.2.2.2 Renal EPD Market
    • 5.2.2.3 Other EPD Market
  • 5.2.3 Market Drivers and Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Leading Competitors
  • 5.3.2 Emerging Competitors

6.0 INFERIOR VENA CAVA FILTER MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Procedures
  • 6.2.1.1 Filter Retrieval
  • 6.2.2 Market Forecast
  • 6.2.3 Market Drivers and Limiters
• 6.3 Competitive Analysis
  • 6.3.1 Leading Competitors
  • 6.3.2 Emerging Competitors

7.0 AORTIC STENT GRAFT MARKET

• 7.1 Market Overview
• 7.2 Market Analysis
  • 7.2.1 Procedures
    • 7.2.1.1 Abdominal Aortic Aneurysm Procedures
    • 7.2.1.2 Thoracic Aorta Procedures
  • 7.2.2 Market Forecast
    • 7.2.2.1 Abdominal Aortic Aneurysm Stent Graft Market
    • 7.2.2.2 Thoracic Stent Graft Market
  • 7.2.3 Market Drivers and Limiters
• 7.3 Competitive Analysis
  • 7.3.1 Leading Competitors
  • 7.3.2 Emerging Competitors

8.0 SYNTHETIC SURGICAL GRAFT MARKET

• 8.1 Market Overview
• 8.2 Market Analysis
  • 8.2.1 Procedures
    • 8.2.1.1 ePTFE Graft Procedures
      • 8.2.1.1.1 Arteriovenous Access Procedures
      • 8.2.1.1.2 Lower Extremity Bypass Procedures
      • 8.2.1.1.3 Other Bypass Procedures
    • 8.2.1.2 Dacron Procedures
      • 8.2.1.2.1 AAA Surgical Procedures
      • 8.2.1.2.2 Thoracic Aortic Surgical Procedures
      • 8.2.1.2.3 Extra-Anatomical Bypass Procedures
      • 8.2.1.2.4 Aorto-Iliac Bypass Procedures
    • 8.2.2 Market Forecast
      • 8.2.2.1 ePTFE Surgical Graft Market
        • 8.2.2.1.1 Arteriovenous Access Synthetic Graft Market
        • 8.2.2.1.2 Lower Extremity Bypass Graft Market
        • 8.2.2.1.3 Other Peripheral Bypass Graft Market
      • 8.2.2.2 Dacron Surgical Graft Market
        • 8.2.2.2.1 AAA Surgical Graft Market
        • 8.2.2.2.2 Thoracic aortic Surgical Graft Market
        • 8.2.2.2.3 Extra-Anatomical Surgical Graft Market
        • 8.2.2.2.4 Aorto-Iliac Bypass Graft Market
  • 8.2.3 Market Drivers and Limiters
• 8.3 Competitive Analysis

9.0 ACCESSORY DEVICE MARKET

• 9.1 Market Overview
• 9.2 Market Analysis
  • 9.2.1 Procedures
    • 9.2.1.1 PV Guidewires
    • 9.2.1.2 PV Diagnostic Catheters
    • 9.2.1.3 PV Sheaths
    • 9.2.1.4 PV Guiding Catheters
  • 9.2.2 Market Forecast
    • 9.2.2.1 PV Guidewire Market
    • 9.2.2.2 PV Diagnostic Catheter Market
    • 9.2.2.3 PV Sheath Market
    • 9.2.2.4 PV Guiding Catheter Market
  • 9.2.3 Market Drivers and Limiters
• 9.3 Competitive Analysis

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit ES-1: PV Device Market, by Device, as a % of Total, US, 2006
• Exhibit ES-2: PV Device Market, by Device, as a % of Total, US, 2005-2011
• Exhibit ES-3: PV Stent Market, by Indication, US (US$), 2005-2011
• Exhibit ES-4: PTA Balloon Catheter Market, by Type, as a % of Total, US, 2005-2011
• Exhibit ES-5: EPD Market, by Indication, US (US$), 2005-2011
• Exhibit ES-6: IVCF Market, by Type, as a % of Total, US, 2005-2011
• Exhibit ES-7: Aortic Procedures, by Type, US, 2005-2011
• Exhibit ES-8: Synthetic Surgical Graft Market, by Indication, as a % of Total, US, 2006
• Exhibit ES-9: PV Diagnostic and Interventional Procedures, US, 2005-2011
• Exhibit ES-10: Leading Competitors in the PV Market, US, 2006

CHAPTER 1: US PERIPHERAL VASCULAR DEVICE OVERVIEW

• Exhibit 1-1: PVD Treatment Morbidities and Length of Stay, by Indication
• Exhibit 1-2: PVD Endovascular and Surgical Patency Rates, by Indication
• Exhibit 1-3: EPD Device Descriptions, by Device Type
• Exhibit 1-4: EPD Device Descriptions, by Device Type (Continued)
• Exhibit 1-5: Rupture Risk of Untreated AAA
• Exhibit 1-6: Vena Cava Filter Indications

CHAPTER 2: US PERIPHERAL VASCULAR DEVICE MARKET

• Exhibit 2-1: PV Device Market, US (US$), 2005-2011
• Exhibit 2-2: PV Device Market, by Device, as a % of Total, US, 2006 and 2011
• Exhibit 2-3: PV Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 2-4: PV Procedures, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 2-5: Total PV Procedures, by Device Type, US, 2005-2011
• Exhibit 2-6: ATK Procedures, by Device Type, US, 2005-2011
• Exhibit 2-7: BTK Procedures, by Device Type, US, 2005-2011
• Exhibit 2-8: PV Market, by Device, US, 2005-2011 (Graphical Format)
• Exhibit 2-9: PV Market, by Device, US (US$), 2005-2011 (Tabular Format)
• Exhibit 2-10: Drivers of the PV Device Market, US
• Exhibit 2-11: Limiters of the PV Device Market, US
• Exhibit 2-12: Leading Competitors in the US PV Device Market, by Device, 2006

CHAPTER 3: PERIPHERAL VASCULAR STENT MARKET

• Exhibit 3-1: PV Stent Market, US (US$), 2005-2011
• Exhibit 3-2: PV Stent Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 3-3: PV Stent Procedures, by Type, US, 2005-2011
• Exhibit 3-4: PV Stent Procedure Growth, by Type, US, 2005-2011
• Exhibit 3-5: BMS Procedures, US, 2005-2011
• Exhibit 3-6: CS Units, by Indication, US, 2005-2011 (Graphical Format)
• Exhibit 3-7: CS Units, by Indication, US, 2005-2011 (Tabular Format)
• Exhibit 3-8: PV Stent Units, by Indication and Type, as a % of Total, US, 2006
• Exhibit 3-9: PV Stent Units, by Type and Indication, US, 2006
• Exhibit 3-10: PV Stent Procedures and Units, by Indication, US, 2005-2011
• Exhibit 3-11: PV Stent Procedure and Unit Growth, by Indication, US, 2006-2011
• Exhibit 3-12: PV Stent Procedures and Units, by Indication, as a % of Total, US, 2005-2011
• Exhibit 3-13: PV Stent Units, by Indication and Type, as a % of Total, US, 2006
• Exhibit 3-14: PV Stent Market, by Type, US (US$), 2005-2011
• Exhibit 3-15: BMS Market, US (US$), 2005-2011
• Exhibit 3-16: PV Stent Market, by Type, US (US$), 2005-2011
• Exhibit 3-17: PV Stent Market Growth, by Type, US, 2006-2011
• Exhibit 3-18: PV Stent Market, by Indication, US (US$), 2005-2011 (Graphical Format)
• Exhibit 3-19: PV Stent Market, by Indication, as a % of Total, US, 2006 and 2011
• Exhibit 3-20: PV Stent Market, by Indication, US (US$), 2005-2011 (Tabular Format)
• Exhibit 3-21: PV Stent Market Growth, by Indication, US, 2006-2011
• Exhibit 3-22: PV Stent Market, by Indication, as a % of Total, US, 2005-2011
• Exhibit 3-23: Drivers of the PV Stent Market, US
• Exhibit 3-24: Limiters of the PV Stent Market, US
• Exhibit 3-25: Leading Competitors in the PV Stent Market, by Type, US, 2006
• Exhibit 3-26: Leading Competitors in the PV Stent Market, by Indication, US, 2006

CHAPTER 4: PTA BALLOON CATHETER MARKET

• Exhibit 4-1: PTA Balloon Catheter Market, US (US$), 2005-2011
• Exhibit 4-2: Primary Indications, by PTA Balloon Catheter Type
• Exhibit 4-3: PTA Balloon Catheter Procedures and Units, by Indication and Type, US, 2006
• Exhibit 4-4: PTA Balloon Catheter Procedures, by Indication and Type, as a % of Total, US, 2006 (Tabular Format)
• Exhibit 4-5: PTA Balloon Catheter Procedures, by Indication and Type, as a % of Total, US, 2006 (Graphical Format)
• Exhibit 4-6: PTA Balloon Catheter Procedures, by Type, US, 2005-2011
• Exhibit 4-7: PTA Procedures, by Indication, US, 2005-2011
• Exhibit 4-8: PTA Procedures, by Indication, US, 2005-2011
• Exhibit 4-9: PTA Procedure Growth and % of Total, by Indication, US, 2005-2011
• Exhibit 4-10: POBA Procedures, by Indication, US, 2005-2011
• Exhibit 4-11: POBA Procedures, by Indication, US, 2005-2011
• Exhibit 4-12: POBA Procedures, by Indication, as a % of Total, US, 2005-2011
• Exhibit 4-13: PTA with Stenting Procedures, by Indication, US, 2005-2011
• Exhibit 4-14: PTA with Stenting Procedures, by Indication, US, 2005-2011
• Exhibit 4-15: PTA with Stenting Procedures, by Indication, as a % of Total, US, 2005-2011
• Exhibit 4-16: PTA with Stenting Procedures, by Usage Type, as a % of Stent Procedures, US, 2006
• Exhibit 4-17: PTA Balloon Catheter Market, US (US$), 2005-2011 (Tabular Format)
• Exhibit 4-18: PTA Balloon Catheter Market, by Type, US (US$), 2005-2011 (Graphical Format)
• Exhibit 4-19: PTA Balloon Catheter Market, by Type, US (US$), 2005-2011 (Tabular Format)
• Exhibit 4-20: PTA Balloon Catheter Market Growth, by Type, US, 2006-2011
• Exhibit 4-21: PTA Balloon Catheter Market, by Type, as a % of Total, US, 2005-2011 (Graphical Format)
• Exhibit 4-22: PTA Balloon Catheter Market, by Type, as a % of Total, US, 2005-2011 (Tabular Format)
• Exhibit 4-23: Drivers of the PTA Balloon Catheter Market, US
• Exhibit 4-24: Limiters of the PTA Balloon Catheter Market, US
• Exhibit 4-25: Leading Competitors in the PTA Balloon Catheter Market, by Device Type, US, 2006

CHAPTER 5: EMBOLIC PROTECTION DEVICE MARKET

• Exhibit 5-1: EPD Market, US (US$), 2005-2011
• Exhibit 5-2: EPD Procedures, by Indication, as a % of Total, US, 2005-2011
• Exhibit 5-3: EPD Procedures, by Indication, US, 2005-2011
• Exhibit 5-4: CAS Clinical Trial Update, 2006
• Exhibit 5-5: CAS Clinical Trial Update, 2006 (Continued)
• Exhibit 5-6: Important CAS with EPD Trial Results
• Exhibit 5-7: Carotid Stent Procedures and EPD Penetration, US, 2005-2011
• Exhibit 5-8: Renal Stent Procedures and EPD Penetration, US, 2005-2011
• Exhibit 5-9: EPD Market, by Indication, US (US$), 2005-2011 (Graphical Format)
• Exhibit 5-10: EPD Market, by Indication, US (US$), 2005-2011 (Tabular Format)
• Exhibit 5-11: EPD Market Growth, by Indication, US, 2006-2011
• Exhibit 5-12: EPD Units and Market Value, by Indication, as a % of Total, US, 2005-2011
• Exhibit 5-13: Carotid EPD Market, US (US$), 2005-2011
• Exhibit 5-14: Carotid EPD Market Growth, US, 2006-2011
• Exhibit 5-15: Renal EPD Market, US (US$), 2005-2011
• Exhibit 5-16: Renal EPD Market Growth, US, 2006-2011
• Exhibit 5-17: Drivers of the EPD Market, US
• Exhibit 5-18: Limiters of the EPD Market, US
• Exhibit 5-19: Leading Competitors in the EPD Market, by Indication, US, 2006
• Exhibit 5-20: Overview of EPDs, US, 2006
• Exhibit 5-21: Overview of EPDs, US, 2006 (Continued)
• Exhibit 5-22: CAS EPD Specifics

CHAPTER 6: INFERIOR VENA CAVA FILTER MARKET

• Exhibit 6-1: IVCF Market, US (US$), 2005-2011
• Exhibit 6-2: Complications Associated with IVCF Use
• Exhibit 6-3: Indicated Safe Time of Removal for Retrievable IVCFs, 2006
• Exhibit 6-4: IVCF Units and Retrievable Kits, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 6-5: IVCF Units, by Type, as a % of Total, US, 2005-2011
• Exhibit 6-6: IVCF Units and Retrievable Kits, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 6-7: IVCF Market, by Type, US (US$), 2005-2011 (Graphical Format)
• Exhibit 6-8: IVCF Revenues, by Type, as a % of Total, US, 2005-2011
• Exhibit 6-9: IVCF Market, by Type, US (US$), 2005-2011 (Tabular Format)
• Exhibit 6-10: IVCF Market Growth, by Type, US, 2006-2011
• Exhibit 6-11: IVCF Market, by Type, as a % of Total, US, 2005-2011
• Exhibit 6-12: Drivers of the IVCF Market, US
• Exhibit 6-13: Limiters of the IVCF Market, US
• Exhibit 6-14: Leading Competitors in the IVCF Market, by Type, US, 2006

CHAPTER 7: AORTIC STENT GRAFT MARKET

• Exhibit 7-1: Aortic Stent Graft Market, US (US$), 2005-2011
• Exhibit 7-2: AAA Stent Graft Device Overview, US, 2006
• Exhibit 7-3: Thoracic Stent Graft Device Overview, US, 2006
• Exhibit 7-4: FDA Approved AAA Stent Graft Clinical Trial Overview
• Exhibit 7-5: Aortic Stent Graft Procedures, by Indication, US, 2005-2011 (Graphical Format)
• Exhibit 7-6: Aortic Stent Graft Procedures, by Indication, US, 2005-2011 (Tabular Format)
• Exhibit 7-7: AAA Stent Graft Penetration into Total AAA Procedures, US, 2005-2011
• Exhibit 7-8: Location of Thoracic Aortic Surgical Procedures, as a % of Total, US, 2006
• Exhibit 7-9: Thoracic Aortic Procedures, by Type, US, 2005-2011
• Exhibit 7-10: Thoracic Aortic Procedures, by Indication, US, 2005-2011
• Exhibit 7-11: Aortic Stent Graft Market, by Indication, US (US$), 2005-2011 (Graphical Format)
• Exhibit 7-12: Aortic Stent Graft Market, by Indication, US (US$), 2005-2011 (Tabular Format)
• Exhibit 7-13: Aortic Stent Graft Market, by Indication, as a % of Total, US, 2005-2011 (Graphical Format)
• Exhibit 7-14: Aortic Stent Graft Market, by Indication, as a % of Total, US, 2005-2011 (Tabular Format)
• Exhibit 7-15: AAA Stent Graft Market, US (US$), 2005-2011
• Exhibit 7-16: Thoracic Aortic Stent Graft Market, US (US$), 2005-2011
• Exhibit 7-17: Drivers of the Aortic Stent Graft Market, US
• Exhibit 7-18: Drivers of the Aortic Stent Graft Market, US (Continued)
• Exhibit 7-19: Limiters of the Aortic Stent Graft Market, US
• Exhibit 7-20: Leading Competitors in the US Aortic Stent Graft Market, Type, 2006
• Exhibit 7-21: W.L. Gore' s TAG Device Pivotal Study Results

CHAPTER 8: SYNTHETIC SURGICAL GRAFT MARKET

• Exhibit 8-1: Synthetic Surgical Graft Market, US (US$), 2005-2011
• Exhibit 8-2: Synthetic Surgical Graft Materials by Primary Indications
• Exhibit 8-3: Synthetic Surgical Graft Procedures, US, 2005-2011
• Exhibit 8-4: Synthetic Surgical Graft Procedures, by Indication, as a % of Total, US, 2005-2011 (Graphical Format)
• Exhibit 8-5: Synthetic Surgical Graft Procedures, by Indication, US, 2005-2011
• Exhibit 8-6: Synthetic Surgical Graft Procedures, by Indication, as a % of Total, US, 2005-2011 (Tabular Format)
• Exhibit 8-7: Synthetic Surgical Graft Procedures, by Material, US, 2005-2011
• Exhibit 8-8: Synthetic Surgical Graft Market, by Material, US (US$), 2005-2011 (Graphical Format)
• Exhibit 8-9: Synthetic Surgical Graft Market, by Material, US (US$), 2005-2011 (Tabular Format)
• Exhibit 8-10: Synthetic Surgical Graft Market Growth, by Material, US, 2006-2011
• Exhibit 8-11: Synthetic Surgical Graft Market, by Indication, US (US$), 2005-2011 (Graphical Format)
• Exhibit 8-12: Synthetic Surgical Graft Market, by Indication, US (US$), 2005-2011 (Tabular Format)
• Exhibit 8-13: Synthetic Surgical Graft Market Growth, by Indication, US, 2006-2011
• Exhibit 8-14: Synthetic Surgical Graft Market, by Indication, as a % of Total, US, 2005-2011
• Exhibit 8-15: Drivers of the Synthetic Surgical Graft Market, US
• Exhibit 8-16: Limiters of the Synthetic Surgical Graft Market, US
• Exhibit 8-17: Leading Competitors in the Synthetic Surgical Graft Market, by Material, US, 2006

CHAPTER 9: ACCESSORY DEVICE MARKET

• Exhibit 9-1: Accessory Device Market, US (US$), 2005-2011
• Exhibit 9-2: PV Procedures, by Type, US, 2005-2011 (Tabular Format)
• Exhibit 9-3: PV Procedures, by Type, US, 2005-2011 (Graphical Format)
• Exhibit 9-4: Best Selling PV Guidewires, by Type, US, 2006
• Exhibit 9-5: Best Selling PV Diagnostic Catheters, by Type
• Exhibit 9-6: Best Selling PV Sheaths, by Type
• Exhibit 9-7: Best-Selling PV Guiding Catheters, US, 2006
• Exhibit 9-8: PV Accessory Device Market, by Device, US (US$), 2005-2011 (Graphical Format)
• Exhibit 9-9: PV Accessory Device Market, by Device, US (US$), 2005-2011 (Tabular Format)
• Exhibit 9-10: PV Accessory Device Market, by Device, US, 2006 and 2011
• Exhibit 9-11: PV Guidewire Market, by Type, US (US$), 2005-2011
• Exhibit 9-12: PV Guidewire Market Growth, by Type, US, 2006-2011
• Exhibit 9-13: PV Diagnostic Catheter Market, by Type, US (US$), 2005-2011
• Exhibit 9-14: PV Diagnostic Catheter Market Growth, by Type, US, 2006-2011
• Exhibit 9-15: PV Sheath Market, by Type, US (US$), 2005-2011
• Exhibit 9-16: PV Sheath Market Growth, by Type, US, 2006-2011
• Exhibit 9-17: PV Guiding Catheter Market, US (US$), 2005-2011
• Exhibit 9-18: Drivers of the Accessory Device Market, US
• Exhibit 9-19: Limiters of the Accessory Device Market, US
• Exhibit 9-20: Leading Competitors in the Accessory Device Market, US, 2006